Rinvoq, an AbbVie JAK inhibitor immunology drug, was the No. 1 prescription pharmaceutical brand when it came to estimated national TV ad spend in 2022, according to iSpot.tv data shared with FiercePharma. It spent about $315.8 million on TV ads during the year, a noticeable increase from its